InsidersTradesSigma
Follow the 华纳药厂 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 华纳药厂 has logged 2 reports. Market capitalisation: €5.6bn. The latest transaction was reported on 15 December 2022 (Sale). Among the most active insiders: 金焰. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华纳药厂 is a company in the health and pharmaceutical sector, listed on the XSHG market. It specializes in the research and development of innovative drugs.